1. Home
  2. CNC vs RMD Comparison

CNC vs RMD Comparison

Compare CNC & RMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Centene Corporation

CNC

Centene Corporation

SELL

Current Price

$68.88

Market Cap

33.1B

Sector

Health Care

ML Signal

SELL

Logo ResMed Inc.

RMD

ResMed Inc.

SELL

Current Price

$235.04

Market Cap

34.0B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
CNC
RMD
Founded
1984
1989
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
33.1B
34.0B
IPO Year
2001
1996

Fundamental Metrics

Financial Performance
Metric
CNC
RMD
Price
$68.88
$235.04
Analyst Decision
Buy
Buy
Analyst Count
21
20
Target Price
$71.78
★ $250.22
AVG Volume (30 Days)
★ 3.0M
1.0M
Earning Date
10-27-2026
10-29-2026
Dividend Yield
N/A
★ 1.13%
EPS Growth
N/A
★ 9.67
EPS
5.30
★ 10.43
Revenue
★ $194,777,000,000.00
$2,957,013,000.00
Revenue This Year
$11.22
$2.67
Revenue Next Year
N/A
$6.32
P/E Ratio
★ $12.67
$22.52
Revenue Growth
★ 19.44
13.44
52 Week Low
$31.63
$180.27
52 Week High
$69.63
$277.67

Technical Indicators

Market Signals
Indicator
CNC
RMD
Relative Strength Index (RSI) 66.24 65.20
Support Level $62.98 $217.41
Resistance Level N/A $242.40
Average True Range (ATR) 1.90 4.50
MACD 0.67 1.41
Stochastic Oscillator 97.12 88.16

Price Performance

Historical Comparison
CNC
RMD

About CNC Centene Corporation

Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 20 million medical members as of December 2025, mostly in Medicaid (about 64% of membership), the individual exchanges (about 28%), and Medicare (about 5%). The company also provides Medicare Part D pharmaceutical plans.

About RMD ResMed Inc.

ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.

Share on Social Networks: